Related Experiment Video
Updated: Jun 2, 2025

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
The First Case of Candida auris Detection and Infection Control in a Pediatric Bone Marrow Transplant Child Patient
Liu Yang1, Kaiting Hong2, Jiajia Luo1
1Department of Clinical Laboratory, Guangxi International Zhuang Medicine Hospital, Nanning, Guangxi, People's Republic of China.
Abstract:
Candida auris is an emerging yeast species and an opportunistic pathogen. Due to its multi-drug resistance and ability to colonize and transmit, it poses a significant risk for outbreaks in medical institutions. In this study, we report the first case of C. auris detected in a pediatric bone marrow transplant child patient in Guangxi, China. C. auris was isolated from urine and identified using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry, and the isolate belonged to clade I using sequencing. We have implemented stringent infection control measures including personal protective equipment and treatment in a single room, and conducted regular surveillance screening of patients' body surfaces, as well as those of related medical and logistics personnel, medical equipment, and surrounding environmental surfaces. These measures aim to effectively control the colonization of C. auris in patients, prevent its spread within hospitals, and ensure the quality of diagnosis and treatment for patients.
Insights
This study reports the first pediatric case of the emerging fungal pathogen Candida auris in a bone marrow transplant patient in China. Strict infection control measures were implemented to manage this multi-drug resistant yeast.
Area of Science:
- Infectious Diseases
- Mycology
- Public Health
Background:
- Candida auris is an emerging, multi-drug resistant yeast and opportunistic pathogen.
- Its ability to colonize and transmit poses a significant risk for healthcare-associated outbreaks.
- This organism is a growing global health concern, particularly in vulnerable patient populations.

